BIMI International Medical Inc.
BIMI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $1 | $2 | $2 | $2 |
| + Debt | $4 | $4 | $5 | $5 |
| Enterprise Value | $4 | $3 | $4 | $3 |
| Revenue | $3 | $6 | $3 | -$5 |
| % Growth | -54.6% | 73.8% | 158.9% | – |
| Gross Profit | $0 | $3 | $2 | -$8 |
| % Margin | 4.6% | 51.9% | 52.8% | 142.7% |
| EBITDA | -$3 | $1 | -$1 | -$8 |
| % Margin | -122.8% | 23.1% | -24.1% | 145% |
| Net Income | -$3 | $1 | -$1 | -$12 |
| % Margin | -124% | 19% | -27.6% | 217.2% |
| EPS Diluted | -0.49 | 0.23 | -0.23 | -4.14 |
| % Growth | -313% | 200% | 94.4% | – |
| Operating Cash Flow | -$1 | -$1 | $3 | -$3 |
| Capital Expenditures | -$1 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | $3 | -$3 |